Free-to-use software version available for academic and non-profit researchers worldwide Intuitive system provides robust data management tools to support scientific collaboration and engagement with funding bodies through streamlined adherence to FAIR data principles  Silverstone, UK: Lab Thread Ltd, a UK-based life science software company, today announced the release of a free of charge version of […]

Partnership combines Inocras’s clinical grade cancer diagnostics and analytics solutions with NDS’s cloud and secure data environment infrastructure SAN DIEGO & SEOUL, South Korea — Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced a strategic partnership with NDS Corporation (NDS), a South Korean […]

Siemens brings world-class capabilities in industrial AI, digital twin technology, and engineering to DOE’s Genesis Mission, building on its longstanding collaboration Today, Siemens announced it has signed a Memorandum of Understanding (MOU) with the U.S. Department of Energy (DOE) to support the Genesis Mission, a federal initiative to modernize America’s scientific infrastructure and strengthen the […]

Genomenon’s Curation and Global Distribution of Variant Data Reduces Barriers to Genetic Diagnosis ANN ARBOR, Mich. – Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease. Through this collaboration, Genomenon produced literature-derived real-world evidence by applying fit-for-purpose AI and expert review to curate and classify variants in […]

Purpose-built enterprise SaaS solution streamlines bioprocess workflows and accelerates digital transformation for global biopharmaceutical development Basel, Switzerland — Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess® enterprise platform to structure and harmonize all bioprocess development data across its operations. […]

-Trusted, unified laboratory informatics designed for fast go-lives and incremental scale- LabWare, a global leader in laboratory informatics, showcases at this year’s Pittcon Conference how laboratories can move away from legacy, slow-to-change LIMS models and adopt low-cost, fast-to-implement SaaS LIMS grounded in industry best practices. The press briefing will focus on how LabWare helps labs […]

— Next-Generation Platform Extends LIMS with Agentic AI and Cloud-Native Automation to Improve Efficiency, Reduce Errors and Gain Deeper Insight from Data — — Learn More from LabVantage Leadership at Pittcon 2026 — SOMERSET, NJ – LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, […]

Zurich – BC Platforms, a global leader in healthcare data, technology, and analytics today announced enhancements to BC Mosaic, its AI-powered trusted research environment (TRE), now available on AWS Marketplace. Featuring an all-new, intuitive user interface, BC Mosaic enables secure, compliant analysis of complex clinical, real-world, and multi-omics data within a single trusted research environment. Designed to make trusted […]

Berlin – The MOLNÁR-INSTITUTE for Applied Chromatography has produced a new version of its Automation Module that is now compatible with Agilent’s OpenLab CDS chromatography data system software. DryLab® Automation module was previously available only for the Waters Empower CDS platform. Empower CDS users were able to benefit from the extended DryLab® functionality that included […]

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. RADNOR, Pa. — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic (PBPK) modeling predictions accepted by the U.S. FDA in lieu of clinical studies to support the new drug application […]